Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Mario Rodríguez et al.|European Journal Of Haematology|2020Cited by 96
Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)Ramón García‐Sánz, Carmen Martı́nez, Anna Sureda et al.|Blood|2016Cited by 47
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez Ubieto, Santiago Barrio, María Poza et al.|Leukemia|2023Cited by 40
Real-Life Disease Monitoring in Follicular Lymphoma Patients Using Liquid Biopsy Ultra-Deep Sequencing and PET/CTAna Jiménez Ubieto, Santiago Barrio, María Poza et al.|Research Square|2022Cited by 4
Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)José Luís Fuster, Monica López‐Duarte, Alexandra Regueiro et al.|Frontiers in Pediatrics|2023Cited by 3